Gender-affirming hormone therapy and liver diseases: a cohort study
The purpose of this study was to describe the incidence of liver-related outcomes, including liver disease and hepatic injury, in transgender and gender diverse (TGD) individuals receiving oestrogen-based or testosterone-based gender-affirming hormone therapy (GAHT). In this retrospective cohort study, we us...